Bechara, Falk G

Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials

Kimball, A. B., Jemec, G. B. E., Alavi, A., Reguiai, Z., Gottlieb, A. B., Bechara, F. G., Paul, C., Giamarellos Bourboulis, E. J., Villani, A. P., Schwinn, A., et al. (2023) · The Lancet

Hidradenitis Suppurativa and TreatmentsAutoimmune and Inflammatory Disorders

Cited by 343

Cutaneous lesions of the external ear

Sand, M., Sand, D., Brors, D., Altmeyer, P., Mann, B., & Bechara, F. G. (2008) · Head & Face Medicine

Reconstructive Facial Surgery TechniquesNonmelanoma Skin Cancer Studies

Cited by 70

Impact of UVA exposure on psychological parameters and circulating serotonin and melatonin

Gambichler, T., Bader, A., Vojvodic, M., Bechara, F. G., Sauermann, K., Altmeyer, P., & Hoffmann, K. (2002) · BMC Dermatology

Skin Protection and AgingCircadian rhythm and melatonin

Cited by 44